Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Foscavir. Always confirm against the full prescribing information.
100 interactions
Aceclofenac
The risk or severity of nephrotoxicity can be increased when Aceclofenac is combined with Foscarnet.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Foscarnet.
Level 1 evidence
Acyclovir
The risk or severity of nephrotoxicity can be increased when Acyclovir is combined with Foscarnet.
Level 1 evidence
Adefovir dipivoxil
The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Foscarnet.
Level 1 evidence
Adenovirus type 7 vaccine live
The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Foscarnet.
Level 2 evidence
Alendronic acid
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Foscarnet is combined with Alendronic acid.
Level 2 evidence
Amikacin
The risk or severity of nephrotoxicity can be increased when Amikacin is combined with Foscarnet.
Level 1 evidence
Amiodarone
The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Amiodarone.
Level 2 evidence
Amphotericin B
The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Foscarnet.
Level 1 evidence
Anagrelide
The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Anagrelide.
Level 2 evidence
Anthrax vaccine
The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Foscarnet.
Level 2 evidence
Antipyrine
The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Foscarnet.
Foscavir (Foscarnet Sodium) has 701 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Foscavir (Foscarnet Sodium) has 8 major, 177 moderate, and 516 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Foscavir. Always confirm against the full prescribing information.